- Pricing equity. We need better worldwide pricing equity for all U.S. purchasers — not just Medicare. This proposal only applies to U.S. purchasers.
- Defined value. Consider individualized appropriateness, real world outcomes and relative costs against other treatment options. This proposal would only improve the market’s focus on real value rather than rebates.